Vilon 20mg

Description

Vilon 20mg is a short synthetic dipeptide composed of the amino acids lysine and glutamic acid, commonly written as Lys-Glu or KE.

Despite containing only two amino acids, Vilon has attracted research interest as part of the broader field of short peptide bioregulators. Published experimental work has explored its relationship with chromatin structure, gene-expression mechanisms, lymphocyte activity, thymocyte proliferation, cellular differentiation, and inflammatory signaling.

A significant portion of the Vilon literature comes from cellular, animal, and earlier bioregulator research rather than large modern human clinical trials. For that reason, Vilon is best described as an emerging experimental peptide rather than a compound with established therapeutic effects. Research involving aged-rat models, for example, has examined Vilon in connection with age-associated physiological changes. 

Common research areas: cellular aging, chromatin regulation, gene expression, thymic signaling, immune-cell activity, cellular differentiation, and peptide bioregulation.

Product Strength: 20mg

Vilon is not an FDA-approved medication, and much of its proposed biological activity remains based on preclinical and cell-based research.